Insider Transactions in Q2 2021 at Elevance Health, Inc. (ELV)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 26
2021
|
Bahija Jallal Director |
BUY
Grant, award, or other acquisition
|
Direct |
493
+14.52%
|
-
|
|
May 26
2021
|
Lewis Hay Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
493
+4.87%
|
-
|
|
May 26
2021
|
Elizabeth E Tallett Director |
BUY
Grant, award, or other acquisition
|
Direct |
493
+5.19%
|
-
|
|
May 26
2021
|
Robert L Dixon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
493
+4.95%
|
-
|
|
May 26
2021
|
R Kerry Clark Director |
BUY
Grant, award, or other acquisition
|
Direct |
493
+5.98%
|
-
|
|
May 26
2021
|
Ramiro G Peru Director |
BUY
Grant, award, or other acquisition
|
Direct |
493
+4.72%
|
-
|
|
May 26
2021
|
Ryan M. Schneider Director |
BUY
Grant, award, or other acquisition
|
Direct |
493
+12.62%
|
-
|
|
May 26
2021
|
Antonio F Neri Director |
BUY
Grant, award, or other acquisition
|
Direct |
493
+13.96%
|
-
|
|
May 25
2021
|
John E Gallina EVP & Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
3,301
-6.08%
|
-
|
|
May 24
2021
|
John E Gallina EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
46,444
-11.36%
|
$18,345,380
$395.65 P/Share
|
|
May 24
2021
|
John E Gallina EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
46,444
+9.83%
|
$7,523,928
$162.05 P/Share
|
|
May 24
2021
|
Ramiro G Peru Director |
SELL
Open market or private sale
|
Direct |
1,308
-12.14%
|
$520,584
$398.02 P/Share
|
|
May 21
2021
|
Robert L Dixon Jr Director |
SELL
Open market or private sale
|
Direct |
590
-6.17%
|
$231,280
$392.87 P/Share
|
|
May 20
2021
|
Julie A Hill Director |
SELL
Open market or private sale
|
Direct |
1,308
-4.02%
|
$515,352
$394.0 P/Share
|